Status:
RECRUITING
Sleep Disturbances and Delirium
Lead Sponsor:
University of Ostrava
Collaborating Sponsors:
University Hospital Ostrava
General University Hospital, Prague
Conditions:
Sleep Disturbance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Delirium is a frequent and serious problem in hospitalized patients; it is associated with multiple hospital-acquired complications. There is evidence that the incidence of deliri-um may be minimized ...
Detailed Description
Sleep is one of the most important physiological needs. Sleep disturbances have detri-mental effects on practically all systems and may thus prolong recovery of patients. Studies have documented many ...
Eligibility Criteria
Inclusion
- age over 18 years
- a hospital stay longer than 24 hours
- a hospital stay longer than 36 hours
- hospitalized for at least 72 hours, without previous sleep disturbances, without cognitive impairment
Exclusion
- Patients with cognitive impairment preventing them from cooperating
- Glasgow Coma Scale score below 12
- terminal disease
- previous and current treatment for sleep disturbances
- neurocognitive dysfunction (dementia)
- sedative administration over the last 24 hours
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
3240 Patients enrolled
Trial Details
Trial ID
NCT05402280
Start Date
May 1 2022
End Date
December 31 2025
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ostrava
Ostrava, Česká Republika, Czechia, 70300